Inhaled corticosteroids in the long-term management of asthma
21 results
1 - 21
Anti‐leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children- Nedocromil sodium for chronic asthma in children
- Addition of long‐acting beta2 agonists or long‐acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta‐analysis
- Addition to inhaled corticosteroids of long‐acting beta2‐agonists versus anti‐leukotrienes for chronic asthma
- Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults
- Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
- Azoles for allergic bronchopulmonary aspergillosis associated with asthma
- Omalizumab for asthma in adults and children: Cochrane systematic review
- Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults
- Inhaled corticosteroids for bronchiectasis: Cochrane systematic review
- Azathioprine as an oral corticosteroid sparing agent for asthma: Cochrane systematic review
- Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children
- Remote versus face‐to‐face check‐ups for asthma
- Oxatomide for stable asthma in adults and children
- Home‐based educational interventions for children with asthma
- Digital interventions to improve adherence to maintenance medication in asthma
- Vilanterol and fluticasone furoate for asthma
- Sublingual immunotherapy for asthma